CDK5-mediated hyperphosphorylation of Tau217 impairs neuronal synaptic structure and exacerbates cognitive impairment in Alzheimer’s disease
Abstract Numerous studies have demonstrated that tau phosphorylated at threonine 217 (p-T217) in cerebrospinal fluid (CSF) or plasma is a potential biomarker for Alzheimer’s disease (AD). However, the detailed pathological effects of elevated p-T217 and the mechanisms underlying T217 phosphorylation...
Saved in:
| Main Authors: | Kangyue Fu, Nan Lin, Yiwen Xu, En Huang, Raoli He, Zhixin Wu, Dianbo Qu, Xiaochun Chen, Tianwen Huang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-08-01
|
| Series: | Translational Psychiatry |
| Online Access: | https://doi.org/10.1038/s41398-025-03551-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Elevated 24-hydroxycholesterol levels counteract okadaic acid-induced tau hyperphosphorylation and neuronal morphology impairment
by: Serena Giannelli, et al.
Published: (2025-10-01) -
Ptprd deficiency promotes tau hyperphosphorylation and impairs cognitive function in aged mice
by: Analía Foncea, et al.
Published: (2025-05-01) -
Klotho null mutation leads to retinal degeneration characterized by functional impairment, gliosis, and deposition of amyloid-beta and hyperphosphorylated tau proteins.
by: Zhi-Jia Chen, et al.
Published: (2025-01-01) -
Identification of the sites of tau hyperphosphorylation and activation of tau kinases in synucleinopathies and Alzheimer's diseases.
by: Valeriy Duka, et al.
Published: (2013-01-01) -
Role of Tau Protein Hyperphosphorylation in Diabetic Retinal Neurodegeneration
by: Jingyu Mu, et al.
Published: (2025-01-01)